Multinational drug corporations now put major efforts for anticancer markets in Korea.
activities initially by taking an occasion of launching a breast cancer drug, Tykerb (lapatinib).
Tykerb was approved by...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
